2012
Integrative survival-based molecular profiling of human pancreatic cancer. Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, Calvopina JH, Patel SG, Wu N, Hindoyan A, Farrell JJ, Li X, Dawson DW, Wu H Clinical cancer research : an official journal of the American Association for Cancer Research, 2012 Mar 1, Volume 18, Issue 5, p.1352-63, (2012)
MicroRNA alterations of pancreatic intraepithelial neoplasias. Yu J, Li A, Hong S-M, Hruban RH, Goggins M Clinical cancer research : an official journal of the American Association for Cancer Research, 2012 Feb 15, Volume 18, Issue 4, p.981-92, (2012)
Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Hong S-M, Omura N, Vincent A, Li A, Knight S, Yu J, Hruban RH, Goggins M Clinical cancer research : an official journal of the American Association for Cancer Research, 2012 Feb 1, Volume 18, Issue 3, p.700-12, (2012)
Molecular determinants of retinoic acid sensitivity in pancreatic cancer. Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong S-M, Goggins MG, De Jesus-Acosta A, Laheru D, Maitra A Clinical cancer research : an official journal of the American Association for Cancer Research, 2012 Jan 1, Volume 18, Issue 1, p.280-9, (2012)
2011
Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, Abbruzzese JL, Liu Y-jun, Logsdon CD, Hwu P Clinical cancer research : an official journal of the American Association for Cancer Research, 2011 Nov 15, Volume 17, Issue 22, p.7015-23, (2011)
Pancreatic cancer. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M Lancet, 2011 Aug 13, Volume 378, Issue 9791, p.607-20, (2011)
Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma. Vincent A, Omura N, Hong S-M, Jaffe A, Eshleman J, Goggins M Clinical cancer research : an official journal of the American Association for Cancer Research, 2011 Jul 1, Volume 17, Issue 13, p.4341-54, (2011)
Assessment of chk1 phosphorylation as a pharmacodynamic biomarker of chk1 inhibition. Parsels LA, Qian Y, Tanska DM, Gross M, Zhao L, Hassan MC, Arumugarajah S, Parsels JD, Hylander-Gans L, Simeone DM, Morosini D, Brown JL, Zabludoff SD, Maybaum J, Lawrence TS, et al. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011 Jun 1, Volume 17, Issue 11, p.3706-15, (2011)